There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO – Research Report) and Vaccitech Plc (VACC – Research Report) with bullish sentiments. BridgeBio Pharma (BBIO) In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on BridgeBio Pharma, with a price target of $25.00. The company's shares closed last Thursday at $5.68, close to its 52-week low of $5.15. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-bridgebio-pharma-bbio-vaccitech-plc-vacc?utm_source=advfn.com&utm_medium=referral
Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Vaccitech Charts.
Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Vaccitech Charts.